Global Avascular Necrosis Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Avascular Necrosis Industry Compare Between 2025 And 2029?

The avascular necrosis market has seen robust expansion in recent years. It is forecast to grow from $0.81 billion in 2024 to $0.89 billion in 2025, at a compound annual growth rate (CAGR) of 9.7%. The market’s historical growth can be ascribed to an increase in the aging population, rising alcohol consumption, the development of sports medicine, the expansion of medical tourism, and progress in precision medicine.

The avascular necrosis market is projected to experience robust expansion in the coming years. It is anticipated to reach $1.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. This anticipated growth throughout the forecast period stems from factors such as the increasing occurrence of corticosteroid-associated osteonecrosis, the rising volume of knee replacement and hip surgical procedures, an escalating number of drug authorizations, a greater frequency of road accidents, and a surge in bone injury incidents. Key trends projected for this period encompass technological innovations, sophisticated imaging techniques, AI-driven diagnostic instruments, 3D-printed surgical solutions, regenerative orthobiological treatments, and cellular therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Which Industry Drivers Are Expected To Accelerate The Avascular Necrosis Market From 2025 To 2029?

The avascular necrosis market is anticipated to expand due to an increasing volume of knee replacements and hip surgeries. These surgical interventions are procedures conducted to substitute compromised joints and alleviate discomfort in advanced stages of avascular necrosis. The rise in such operations is attributable to the rising occurrence of osteoarthritis, a condition that leads to intense joint pain and mobility problems, frequently necessitating surgery for relief and a better quality of life. Avascular necrosis itself is a major factor driving the demand for knee and hip replacements, as it involves the death of bone tissue resulting from insufficient blood supply, often culminating in joint degradation and collapse. For example, Curvo Labs, Inc., a US-based healthcare technology company, reported in September 2023 that knee replacement procedures in the U.S. saw an increase from 1,235,835 in 2021 to 1,299,084 in 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is a key factor propelling the avascular necrosis market. Future expansion of the avascular necrosis market is anticipated to be fueled by increasing healthcare expenditure. This refers to the cumulative spending on health services, therapeutic interventions, and medical commodities within a given populace or healthcare infrastructure. Healthcare spending is on the rise, primarily driven by the escalating incidence of chronic illnesses that demand ongoing management, frequent hospitalizations, and expensive medications. For avascular necrosis, greater healthcare expenditure facilitates timely diagnostic services, sophisticated treatment options, and surgical interventions, all of which are crucial for managing the condition and enhancing patient prognoses. For instance, the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, stated in April 2025 that health spending in the United States surged by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, which represents an acceleration from the 4.6% increase observed in 2022. Thus, the growth of the avascular necrosis market is being propelled by rising healthcare expenditure.

What Are The Major Segment Types Covered In The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegment:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Which Key Trends Are Expected To Influence The Avascular Necrosis Market In The Coming Years?

Major companies operating within the avascular necrosis market are actively seeking and obtaining regulatory approvals to broaden their product portfolios, enhance existing treatment options, and strengthen their position in the market. Regulatory approvals signify official permissions provided by health authorities, enabling a medical product or treatment to be marketed and used after successfully meeting all necessary safety and efficacy benchmarks. For example, in May 2022, Regrow Biosciences, an India-based biotechnology company, secured approval from the United States Food and Drug Administration to initiate Phase II clinical trials in the US for OSSGROW. OSSGROW is an orphan drug designated for addressing osteonecrosis, which is another term for avascular necrosis. This pioneering, personalized bone cell therapy was developed by Regrow Biosciences for the curative treatment of avascular necrosis (AVN) in its early to moderate stages (up to Stage III). The therapy functions by extracting mesenchymal stem cells from the patient’s bone marrow, which are then cultivated in a specialized laboratory to develop into bone-forming cells known as osteoblasts. OSSGROW is recognized as a natural, safe, and potentially permanent solution, aiming to provide an alternative to traditional treatments and joint replacement surgeries that currently only manage symptoms.

Which Global Market Leaders Are Shaping The Future Of The Avascular Necrosis Sector?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc., Ginger Healthcare Private Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

How Does The Avascular Necrosis Market Perform Across Key Geographic Regions?

North America was the largest region in the avascular necrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2025, By The Business Research Company

Peripheral Artery Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795